Contemporary Issues in Pituitary Disease: 13th Annual Symposium

Cleveland Clinic Pituitary Symposium


Innovations and advances in the field of pituitary disease – including evaluation, diagnosis, treatment, and prevention – continue to occur at a rapid pace, challenging both specialists and generalists to stay abreast of the data and their implications for clinical practice. This one-day program will include didactic and case-based talks and panel discussions by some of the finest experts in this field.

Who Should Attend?

Endocrinologists, neurosurgeons, family medicine, internal medicine physicians and other allied health professionals who treat and manage patients with pituitary disease.

Learning Objectives

After completing this educational activity, participants will be able to do the following:

  • List the efficacy and side effect profiles of available treatment options for secretory pituitary tumors and discuss their use in clinical practice;
  • Describe the impact of recent evidence on management strategies for patients with diabetes insipidus.
  • Summarize the evidence on pituitary dysfunction in patients treated with immune checkpoint inhibitors.
  • Critically appraise the data supporting use of selective estrogen-receptor modulators for hypogonadotropic hypogonadism and oral somatostatin analog treatment for acromegaly.
  • Debate the issues supporting surgery over medical treatment as the primary treatment for prolactinoma.
  • Describe the indications, risks, and benefits of hormone replacement therapies for hypopituitarism.

For information on registering visit